64987-03-7,
Ethyl 2-(2-formamidothiazol-4-yl)-2-oxoacetate,
ethyl 2-(formylamino)-4-thiazoleglyoxylate,
ETHYL 2-(2-FORMYLAMINO-1,3-THIAZOL-4-YL)-2-OXOACETATE,
(2-Formylaminothiazol-4-yl)-oxo-acetic acid ethyl ester,
Ethyl 2-formamido-alpha-oxothiazol-4-acetate,
Ethyl (2-formamido-1,3-thiazol-4-yl)glyoxylate,
ethyl 2-(2-formamido-1,3-thiazol-4-yl)-2-oxoacetate,
ethyl 2-(2-formylaminothiazol-4-yl)glyoxylate,
W-104810,
Ethyl [2-(formylamino)-1,3-thiazol-4-yl](oxo)acetate,
ethyl 2-(2-carbonylamino(1,3-thiazol-4-yl))-2-oxoacetate,
EINECS 265-299-4,
AC1MBYFY,
DSSTox_CID_31583,
DSSTox_RID_97467,
DSSTox_GSID_57794,
SCHEMBL423212,
CHEMBL3561164,
DTXSID6057794,
Ethyl-2-(2-formylamino-4-thiazole-4-yl)-1-oxy acetate,
SCHEMBL11007124,
CTK5C1986,
NTACMHVXGGGRQU-UHFFFAOYSA-N,
BCP12089,
ZINC2166998,
ZX-AT020423,
Tox21_113773,
MFCD00010412,
SBB057588,
AKOS015897256,
AC-5563,
MCULE-6054778481,
OR28737,
VZ36098,
NCGC00253647-01,
AJ-33815,
AN-10853,
BP-20081,
CC-00386,
CJ-33378,
EN002755,
ethyl 2-formamido-?-oxothiazol-4-acetate,
AX8006361,
CAS-64987-03-7,
DB-017932,
FT-0608468,
ST50306850,
Ethyl 2-(2-formylaminothiazol-4-yl) glyoxylate,
Ethyl 2-(Formylaminothiazol-4-yl)-2-oxoacetate,
A834928,
C-13054,
ethyl 2-(2-formamidothiazol-4-yl)-2-oxo-acetate,
SR-01000944940,
ethyl (2-formamido-1,3-thiazol-4-yl)(oxo)acetate,
I09-0411,
SR-01000944940-1,
ethyl 2-(2-formylamino-1,3-thiazol-4-yl)glyoxylate,
F0001-1751,
N-{4-[Ethoxy(oxo)acetyl]-1,3-thiazol-2-yl}formamide,
2-(2-formamido-4-thiazolyl)-2-oxoacetic acid ethyl ester,
2-(Formylamino)-alpha-oxo-4-thiazoleacetic acid ethyl ester,
4-Thiazoleacetic acid,2-(formylamino)-a-oxo-,ethyl ester,
ethyl 2-(2-formylimino-2,3-dihydrothiazol-4-yl)glyoxylate,
ethyl 2-(2-formamido-1,3-thiazol-4-yl)-2-oxidanylidene-ethanoate,
ethyl 2-(2-formylimino-2,3-dihydro-1,3-thiazol-4-yl)glyoxylate,
ethyl 2-(2formylimino-2,3-dihydro-1,3-thiazol-4-yl)glyoxylate,
ETHYL2- -2-OXOACETATE,
C8-H8-N2-O4-S,
ZINC02166998,
CID2733245,
4-Thiazoleacetic acid, 2-(formylamino)-.alpha.-oxo-, ethyl ester,